These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17584669)

  • 1. Appraisal of BSPM obtained from the limited lead system.
    Sobieszczanska M; Jagielski J; Nowak B; Pilecki W; Kalka D
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():11-3. PubMed ID: 17584669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the diagnosis of bundle branch block by analysis of body surface potential maps.
    Donis V; Guillem MS; Climent AM; Castells F; Chorro FJ; Millet J
    J Electrocardiol; 2009; 42(6):651-9. PubMed ID: 19285681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of body surface potential mapping in coronary artery disease diagnosis.
    Sobieszczanska M; Kalka D; Pilecki W; Nowak B
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():16-9. PubMed ID: 17584671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of extrema on body surface isointegral maps in RBBB].
    Rusiecki L; Sobieszczańska M; Rusiecka M; Pilecki W
    Pol Arch Med Wewn; 2006 Aug; 116(2):756-9. PubMed ID: 17424920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many leads are necessary for a reliable reconstruction of surface potentials during atrial fibrillation?
    Guillem Mde L; Bollmann A; Climent AM; Husser D; Millet-Roig J; Castells F
    IEEE Trans Inf Technol Biomed; 2009 May; 13(3):330-40. PubMed ID: 19423429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-millisecond interventricular difference as assessed by body surface potential mapping identifies patients with clinical improvement after implantation of cardiac resynchronization device.
    Samesima N; Douglas R; Tobias N; Pedrosa A; Martinelli Filho M; Ramires JA; Pastore CA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():213-5. PubMed ID: 17584728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of approximated body-surface-potential-maps by utilizing a common 12-lead-ECG device.
    Koch H; Richter A; Kürsten R; Zabel M
    IEEE Trans Biomed Eng; 2005 Mar; 52(3):463-70. PubMed ID: 15759576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart activation course on isochrone maps in normal subjects].
    Laszki-Szczqchor K; Jagielski J; Sobieszczańska M; Rusiecki L
    Pol Arch Med Wewn; 2006 Jun; 115(6):512-9. PubMed ID: 17263222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of hemodialysis on heart's intraventricular conduction system--pilot study].
    Polak-Jonkisz D; Laszki-Szczachor K; Zwolińska D; Rusiecki L; Miler M; Sobieszczańska M
    Pol Merkur Lekarski; 2009 Apr; 26(154):276-80. PubMed ID: 19580187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lead selection methods for optimal reconstruction of body surface potentials.
    Guillem MS; Castells F; Climent AM; Bodí V; Chorro FJ; Millet J
    J Electrocardiol; 2008; 41(1):26-34. PubMed ID: 17889899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Data base for body surface potential maps of normal populations--normal data base by the Japanese Circulation Society Task Force Committee on Criteria for Body Surface Mapping].
    Ikeda K
    Nihon Rinsho; 1995 Jan; 53(1):61-6. PubMed ID: 7897857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The state of body surface mapping in Japan.
    Watanabe Y
    J Electrocardiol; 1995; 28 Suppl():110-20. PubMed ID: 8656097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of body surface potential mapping for early identification of the intraventricular conduction disorders in young patients with chronic kidney disease.
    Polak-Jonkisz D; Laszki-Szczachor K; Purzyc L; Zwolińska D; Musiał K; Pilecki W; Rusiecki L; Janocha A; Kałka D; Sobieszczańska M
    J Electrocardiol; 2009; 42(2):165-71. PubMed ID: 19237000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Web-based tool for processing and visualizing body surface potential maps.
    Bond RR; Finlay DD; Nugent CD; Moore G
    J Electrocardiol; 2010; 43(6):560-5. PubMed ID: 20655059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repercussions of cardiac resynchronization therapy on the ventricular repolarization of heart failure patients as assessed by body surface potential mapping.
    Pastore CA; Douglas RA; Samesima N; Martinelli Filho M; Nishioka SD; Kaiser E; Ramires JA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():79-81. PubMed ID: 17584688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of body surface potential mapping in cardiac arrhythmias.
    De Ambroggi L; Corlan AD
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():8-10. PubMed ID: 17584668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal electrocardiographic lead systems: practical scenarios in smart clothing and wearable health systems.
    Finlay DD; Nugent CD; Donnelly MP; McCullagh PJ; Black ND
    IEEE Trans Inf Technol Biomed; 2008 Jul; 12(4):433-41. PubMed ID: 18632323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the measuring sensitivity of unipolar and bipolar ECG with lead field method and FDM models.
    Puurtinen M; Viik J; Takano N; Malmivuo J; Hyttinen J
    Comput Methods Programs Biomed; 2009 May; 94(2):161-7. PubMed ID: 19185947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many electrodes and where? A "poldermodel" for electrocardiography.
    Kors JA; van Herpen G
    J Electrocardiol; 2002; 35 Suppl():7-12. PubMed ID: 12539094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of optimal recording sites for limited lead body surface potential mapping in myocardial infarction and left ventricular hypertrophy.
    Finlay DD; Nugent CD; Donnelly MP; Black ND
    J Electrocardiol; 2008; 41(3):264-71. PubMed ID: 18433618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.